http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Diplomat Completes Acquisition of TNH Advanced Specialty Pharmacy
-
Diplomat to Host First "Diplomat Dialogue" in Honor of National Cancer Survivors Day
-
Diplomat to Participate in the William Blair 36th Annual Growth Stock Conference
-
Diplomat Launches 3rd Annual Fellowship and Internship Programs
-
Diplomat's Hepatitis C Coverage Study with Penn Medicine Published and Chosen as Top Editor's Pick
-
Diplomat Announces 1st Quarter Financial Results
-
Diplomat Celebrates World Hepatitis Month with National Multimedia Campaign
-
Diplomat to Dispense CABOMETYX™ (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma
-
Diplomat to Acquire Oncology-Focused TNH Advanced Specialty Pharmacy
-
Diplomat Announces Executive Promotion for Jennifer Hagerman
-
Diplomat to Dispense VENCLEXTA™ for the Treatment of Chronic Lymphocytic Leukemia
-
Diplomat to Host Analyst and Investor Day on May 18, 2016
-
Diplomat to Release First Quarter Operating Results and Host Conference Call on Monday, May 9, 2016
-
Diplomat Announces TALTZ® Availability for the Treatment of Plaque Psoriasis
-
Diplomat Now Dispensing IMBRUVICA® as First-Line Therapy for Chronic Lymphocytic Leukemia
-
Diplomat Celebrates Multiple Sclerosis Week with National Campaign
-
Diplomat's Amy Clarke Elected as President of Immunoglobulin National Society
-
New Michigan Medicaid HCV Formulary Coverage Announced
-
Diplomat Launches Pharmacy Tech Certification Program
-
Diplomat Announces 4th Quarter and 2015 Year End Financial Results; Provides Initial 2016 Guidance
-
Diplomat Announces Executive Promotions for Kaddis and Neill
-
EnvoyHealth Selected by Sun Pharma to Support Imatinib Mesylate Patient Program
-
Diplomat to Participate in the Raymond James & Associates' 37th Annual Institutional Investors Conference
-
Diplomat Pharmacy (DPLO) Begins Filling Prescriptions for ZEPATIER as HCV Treatment (MRK)
-
Diplomat to Dispense ZEPATIER™ to Treat Patients with Chronic Hepatitis C Virus
-
Diplomat to Release Fourth Quarter and Year End Operating Results and Host Conference Call on Monday, February 29, 2016
-
Diplomat Announces Executive Promotion for Paul Urick
-
Diplomat Launches a Reimagined Website at 'Diplomat.is'
-
Diplomat Launches 'AllMetRx™' Care Management Initiative
-
Diplomat Releases 2015 Satisfaction Survey Results
-
Diplomat Announces COSENTYX® Availability for the Treatment of Two New Indications
-
Diplomat's President Elected as Board Chair for American Foundation for Pharmaceutical Education
-
Diplomat Publishes New Report on Specialty Drugs Approved in 2015 and Expected for 2016
-
Diplomat to Participate in the 34th Annual J.P. Morgan Healthcare Conference
-
Diplomat Pharmacy (DPLO) Reaccreditated by URAC for Full Specialty Pharmacy Status
-
Diplomat Receives Full URAC Specialty Pharmacy Reaccreditation
-
Diplomat Pharmacy (DPLO) Launches New Rare COE Program
-
Diplomat Launches New COE Program to Focus on Rare-Disease Populations
-
Diplomat Named Among Top 100 Places to Work by Detroit Free Press
-
Diplomat's Gary Rice to Co-Present Webinar on Health Plan Strategies for Oral Oncology Therapies
-
Burman's Specialty Pharmacy - a Diplomat Company - Collaborate in Landmark Study on Coverage of Hepatitis C Medications with Penn Medicine
-
Diplomat to Dispense Myeloma Drug NINLARO®
-
/C O R R E C T I O N -- Diplomat Pharmacy, Inc./
-
Diplomat to Dispense AstraZeneca Drug TAGRISSO™ (osimertinib)
-
Diplomat to Dispense Melanoma Drug COTELLIC® in Combination with ZELBORAF®
-
Diplomat Announces Executive Promotions for Fleckenstein and Rice
-
Diplomat to Participate in the 24th Annual Credit Suisse Healthcare Conference
-
Diplomat Announces 3rd Quarter Financial Results
-
/C O R R E C T I O N -- Diplomat Pharmacy, Inc./
-
/C O R R E C T I O N -- Diplomat Pharmacy, Inc./

